Professor Anstey undertakes clinical research in malaria and tuberculosis with partners in the Asia-Pacific. He has identified new mechanisms underlying severe malaria, translating these findings to clinical trials of agents to improve blood supply to vital organs. He has also undertaken clinical trials of drugs to treat all three major species causing malaria in our region. He uses results to contribute to policy change nationally, regionally and globally (through WHO). He has over 25 speaking invitations to international conferences and 17 years of NIH funding. He has published 177 articles with over 10,000 citations and has trained 15 PhD students.